Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | dihydrofolate reductase DfrA | 0.1119 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.002 | 0.002 |
Echinococcus multilocularis | dihydrofolate reductase | 0.1119 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0051 | 0.0059 |
Echinococcus granulosus | dihydrofolate reductase | 0.1119 | 1 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0036 | 0.02 | 0.0181 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0016 | 0.002 | 0.002 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0051 | 0.0059 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.0051 | 0.0059 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0051 | 0.0059 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.0324 | 0.0305 |
Echinococcus multilocularis | dna polymerase eta | 0.0044 | 0.0279 | 0.026 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0601 | 0.5313 | 1 |
Mycobacterium tuberculosis | Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) | 0.1119 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0051 | 0.0059 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0118 | 0.0946 | 0.0928 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.002 | 0.002 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0044 | 0.0279 | 0.0489 |
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.0279 | 0.026 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0034 | 0.0183 | 0.0164 |
Brugia malayi | hypothetical protein | 0.0036 | 0.02 | 0.0181 |
Echinococcus granulosus | dna polymerase kappa | 0.0019 | 0.0051 | 0.0032 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0019 | 0.0051 | 0.0051 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0183 | 0.0164 |
Brugia malayi | Zinc finger, C2H2 type family protein | 0.0306 | 0.2642 | 0.2628 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0051 | 0.0336 | 1 |
Echinococcus multilocularis | thymidylate synthase | 0.0106 | 0.0839 | 0.0821 |
Echinococcus granulosus | thymidylate synthase | 0.0106 | 0.0839 | 0.0821 |
Echinococcus multilocularis | zinc finger transcription factor gli2 | 0.0306 | 0.2642 | 0.2628 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0044 | 0.0279 | 0.0489 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0601 | 0.5313 | 1 |
Giardia lamblia | DINP protein human, muc B family | 0.0019 | 0.0051 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.0118 | 0.0946 | 0.0928 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.02 | 1 |
Leishmania major | DNA polymerase eta, putative | 0.0044 | 0.0279 | 0.0489 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0051 | 0.0059 |
Mycobacterium leprae | DIHYDROFOLATE REDUCTASE DFRA (DHFR) (TETRAHYDROFOLATE DEHYDROGENASE) | 0.1119 | 1 | 1 |
Leishmania major | DNA polymerase eta, putative | 0.0031 | 0.016 | 0.0264 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.0051 | 0.0059 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.1119 | 1 | 1 |
Onchocerca volvulus | 0.0106 | 0.0839 | 0.5 | |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0019 | 0.0051 | 0.0051 |
Loa Loa (eye worm) | thymidylate synthase | 0.0106 | 0.0839 | 0.0821 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0051 | 0.0059 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0118 | 0.0946 | 0.0928 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0106 | 0.0839 | 0.0839 |
Brugia malayi | Dihydrofolate reductase | 0.1119 | 1 | 1 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0019 | 0.0051 | 0.0031 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0019 | 0.0051 | 0.0031 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0031 | 0.016 | 0.0264 |
Trypanosoma brucei | unspecified product | 0.0019 | 0.0051 | 0.0059 |
Loa Loa (eye worm) | zinc finger protein | 0.0306 | 0.2642 | 0.2628 |
Schistosoma mansoni | dihydrofolate reductase | 0.1119 | 1 | 1 |
Leishmania major | DNA polymerase kappa, putative | 0.0019 | 0.0051 | 0.0059 |
Brugia malayi | thymidylate synthase | 0.0106 | 0.0839 | 0.0821 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0051 | 0.0059 |
Brugia malayi | hypothetical protein | 0.0051 | 0.0336 | 0.0316 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.0051 | 0.0059 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0051 | 0.0059 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.0324 | 0.0305 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0051 | 0.0059 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.0183 | 0.0183 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0051 | 0.0059 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0036 | 0.02 | 0.0181 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 0.0324 | 0.0305 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.002 | 0.002 |
Echinococcus multilocularis | dna polymerase kappa | 0.0019 | 0.0051 | 0.0032 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.0601 | 0.5313 | 1 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase, putative | 0.0051 | 0.0336 | 0.0596 |
Echinococcus granulosus | dna polymerase eta | 0.0044 | 0.0279 | 0.026 |
Echinococcus granulosus | zinc finger transcription factor gli2 | 0.0306 | 0.2642 | 0.2628 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0019 | 0.0051 | 0.0032 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0019 | 0.0051 | 0.0032 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.02 | 0.02 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0601 | 0.5313 | 1 |
Mycobacterium ulcerans | thymidylate synthase | 0.0106 | 0.0839 | 0.0792 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0019 | 0.0051 | 0.0059 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0019 | 0.0051 | 0.0032 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0051 | 0.0059 |
Chlamydia trachomatis | dihydrofolate reductase | 0.1119 | 1 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0051 | 0.0059 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.02 | 1 |
Schistosoma mansoni | DNA polymerase eta | 0.0044 | 0.0279 | 0.0279 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0019 | 0.0051 | 0.0032 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0044 | 0.0279 | 0.026 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.02 | 1 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0601 | 0.5313 | 1 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.0106 | 0.0839 | 0.0821 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.02 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0051 | 0.0059 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0051 | 0.0059 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0324 | 0.0305 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.0031 | 0.016 | 0.0264 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0036 | 0.02 | 0.02 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.002 | 0.002 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0051 | 0.0336 | 0.0316 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0601 | 0.5313 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.